Home
/ 2cureX
/ Competitors

2cureX Competitors and Similar CompaniesClear all

2cureX's competitors and similar companies include Arrogene, Guardant Health, KEW and Advaite.

	2cureX 2cureX is a biotech company that helps physicians to select an individual drug therapy for their cancer patients.	Arrogene Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.	Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.	KEW KEW is a genomic profiling company specializing in cancer care.	Advaite Advaite is a biotech company focused on developing therapeutics and diagnostics to help patients suffering from debilitating diseases.
Founding Date	Founding Date 2006	Founding Date 2007	Founding Date 2012	Founding Date 2011	Founding Date 2017
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy
Locations	Locations Copenhagen, DK HQ Hamburg, DE	Locations West Hollywood, US HQ	Locations Redwood City, US HQ	Locations Waltham, US HQ Newton, US	Locations Malvern, US HQ Chicago, US
Employees	Employees 14	Employees N/A	Employees 1,7681% decrease	Employees 205% increase	Employees 5
Valuation ($)	Valuation ($) 792.7 k	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $982m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $349m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr10k (FY, 2025)	Gross profit N/A	Gross profit $633m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (kr2.6m) (FY, 2025)	Net income ($1m) (FY, 2015)	Net income ($416.3m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 750k (about 10 years ago)	Latest funding round N/A	Latest funding round $ 16.8m (over 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 3.7m	Total funding raised $ 550m	Total funding raised $ 32.9m	Total funding raised N/A